ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $379,345,000 | -30.0% | 9,385,080 | -0.4% | 0.45% | -20.8% |
| Q2 2015 | $542,294,000 | -11.2% | 9,423,002 | -1.7% | 0.57% | -9.6% |
| Q1 2015 | $610,351,000 | +9.4% | 9,586,157 | +6.1% | 0.63% | +8.0% |
| Q4 2014 | $557,791,000 | +59.8% | 9,034,520 | +0.5% | 0.59% | +52.9% |
| Q3 2014 | $349,033,000 | +23.0% | 8,988,756 | +9.1% | 0.38% | +20.4% |
| Q2 2014 | $283,846,000 | -10.6% | 8,239,358 | +12.2% | 0.32% | -15.4% |
| Q1 2014 | $317,346,000 | +10.7% | 7,344,262 | +2.0% | 0.38% | +5.6% |
| Q4 2013 | $286,755,000 | +5.9% | 7,197,661 | -0.2% | 0.36% | -5.6% |
| Q3 2013 | $270,872,000 | +47.8% | 7,215,568 | +5.8% | 0.38% | +35.0% |
| Q2 2013 | $183,322,000 | – | 6,822,525 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,976,526 | $368,991,000 | 11.95% |
| HWG Holdings LP | 155,584 | $9,606,000 | 6.84% |
| DOWLING & YAHNKE LLC | 676,313 | $41,756,000 | 5.20% |
| Ghost Tree Capital, LLC | 150,000 | $9,261,000 | 4.44% |
| WILLIAM HARRIS INVESTORS INC | 276,870 | $17,094,000 | 4.41% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 61,225 | $3,780,000 | 2.87% |
| Opus Point Partners Management, LLC | 45,418 | $2,804,000 | 2.77% |
| PINNACLE ASSOCIATES LTD | 1,917,838 | $118,407,000 | 2.32% |
| Ghost Tree Capital, LLC | 50,000 | $3,087,000 | 1.48% |
| Adamant Biomedical Investments AG | 100,000 | $6,174,000 | 1.48% |